Skip to Main Content

Paper Details

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 System.
Cancers (Basel)
16
2022
CTC, CTCs, Circulating Tumor Cells, Circulating tumor cells, HER2, MBC, Metastatic Breast Cancer, Patients, RNA, cancer, metastatic breast cancer, participant, patients, surface marker-defined cells, tumor
Author NameAffiliation
Massimo CristofanilliRobert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University
Michael F PressKeck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California
James M ReubenThe University of Texas MD Anderson Cancer Center
Naoto T UenoThe University of Texas MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2